|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.44 CNY | +1.68% |
|
+3.38% | -30.72% |
| Apr. 16 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
| Apr. 03 | Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on February 8, 2024. | CI |
Beijing Hotgen Biotech Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 541.15 million compared to CNY 3,556.55 million a year ago. Net income was CNY 30.16 million compared to CNY 944.74 million a year ago.
Basic earnings per share from continuing operations was CNY 0.34 compared to CNY 10.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.72% | 351M | |
| -2.03% | 187B | |
| -2.76% | 106B | |
| -4.42% | 66.9B | |
| +2.89% | 49.45B | |
| +16.27% | 48B | |
| +4.06% | 40.84B | |
| +2.30% | 26.48B | |
| +2.85% | 26.25B | |
| +12.96% | 24.62B |
BEIJING HOTGEN BIOTECH CO., LTD. 
